Thyroid Disease in Pregnancy for MRCP Part 1

TL;DR

Obs Med: Thyroid Disease in Pregnancy (hCG effect) is a classic endocrine topic in MRCP Part 1, particularly because normal physiological changes can mimic pathology. Human chorionic gonadotropin (hCG) weakly stimulates the TSH receptor, causing transient suppression of TSH in early pregnancy. Candidates are commonly tested on distinguishing physiological changes from Graves’ disease, interpreting thyroid function tests correctly, and recognising treatment pitfalls during pregnancy.

MRCP Part 1: Thyroid Disease in Pregnancy and the hCG Effect

Pregnancy produces major physiological endocrine changes, and thyroid function testing becomes significantly more complex during gestation. In MRCP Part 1, questions frequently focus on interpreting thyroid biochemistry in pregnancy, differentiating physiological adaptations from disease, and identifying safe treatment strategies.

For candidates revising obstetric medicine, thyroid disease is particularly important because it combines endocrinology, physiology, pharmacology, and interpretation of laboratory values — all favourite examination themes.

For a broader revision framework, see the MRCP Part 1 overview and practise integrated endocrine questions in the Free MRCP MCQs.

Why this matters

Maternal thyroid hormones are essential for fetal neurodevelopment, especially during the first trimester before the fetal thyroid gland becomes functional. Even mild thyroid dysfunction can affect pregnancy outcomes.

From an examination perspective, the topic is highly testable because:

1. Pregnancy alters “normal” thyroid physiology.

2. TSH interpretation changes by trimester.

3. hCG can transiently suppress TSH.

4. Graves’ disease and gestational thyrotoxicosis may appear similar.

5. Antithyroid drugs have trimester-specific risks.

MRCP questions commonly present a pregnant woman with abnormal thyroid function tests and ask whether the findings are physiological, pathological, or treatment-related.

Core sections

The hCG effect on the thyroid: the core physiology

Human chorionic gonadotropin (hCG) shares structural similarity with TSH. Because of this, hCG can weakly stimulate the thyroid gland via the TSH receptor.

Peak hCG levels occur at approximately 10–12 weeks’ gestation. This produces:

• Mild increase in free T4 and free T3

• Suppression of pituitary TSH

• Increased thyroid hormone production

In many women, TSH becomes temporarily low or even undetectable during the first trimester without indicating true hyperthyroidism.

This physiological effect is the single most important concept tested in pregnancy thyroid questions.

High-yield thyroid changes in pregnancy

Physiological Change	Mechanism	MRCP Relevance
Increased thyroxine-binding globulin (TBG)	Oestrogen effect	Raises total T4/T3
Lower TSH in first trimester	hCG stimulation	Can mimic thyrotoxicosis
Increased iodine requirement	Increased renal clearance	Risk factor for deficiency
Increased total T4/T3	Elevated TBG	Total hormones less reliable
Slight thyroid enlargement	Hyperplasia and vascularity	Usually mild and diffuse

Key examination point

Free T4 and trimester-specific TSH reference ranges are more useful than total T4 values during pregnancy.

The 5 most tested subtopics

1. Gestational transient thyrotoxicosis

This is physiological thyrotoxicosis caused by high hCG levels.

Common associations include:

• Hyperemesis gravidarum

• Multiple pregnancy

• Trophoblastic disease

Features

• Low TSH

• Mildly elevated free T4

• No thyroid eye disease

• No thyroid antibodies

• Usually self-limiting

Management

• Supportive treatment only

• Antithyroid drugs are usually unnecessary

Exam trap

A low TSH in early pregnancy does not automatically mean Graves’ disease.

2. Graves’ disease in pregnancy

This is the commonest cause of pathological hyperthyroidism during pregnancy.

Clinical clues

• Goitre

• Ophthalmopathy

• Persistent thyrotoxicosis

• Positive TSH receptor antibodies

Treatment principles

Trimester	Preferred Drug
First trimester	Propylthiouracil (PTU)
Second/third trimester	Carbimazole may be used

PTU is preferred initially because carbimazole is associated with embryopathy in early pregnancy.

However, prolonged PTU use carries a risk of hepatotoxicity.

Important MRCP point

Switching from PTU to carbimazole after the first trimester is a classic exam theme.

3. Hypothyroidism in pregnancy

Usually caused by autoimmune thyroiditis.

Risks

• Miscarriage

• Pre-eclampsia

• Prematurity

• Impaired fetal neurodevelopment

Typical findings

• Elevated TSH

• Low free T4

Management

Levothyroxine dose usually needs to increase during pregnancy.

Women with known hypothyroidism are often advised to increase their levothyroxine dose as soon as pregnancy is confirmed.

4. Postpartum thyroiditis

Typically occurs within one year after delivery.

Classical pattern

1. Transient thyrotoxic phase

2. Followed by hypothyroid phase

3. Recovery in many cases

Important distinction

Unlike Graves’ disease:

• Radioiodine uptake is low

• Ophthalmopathy is absent

This distinction frequently appears in single best answer questions.

5. Thyroid function test interpretation in pregnancy

This is arguably the highest-yield subtopic.

Remember:

• TSH may be physiologically low in first trimester.

• Total T4 rises because TBG increases.

• Trimester-specific reference ranges should be used.

A practical exam rule

A mildly suppressed TSH with minimal symptoms in early pregnancy is often physiological.

10 high-yield revision points for MRCP Part 1

1. hCG weakly stimulates TSH receptors.

2. TSH commonly falls during the first trimester.

3. Gestational thyrotoxicosis is usually transient.

4. Graves’ disease is the commonest pathological cause of hyperthyroidism in pregnancy.

5. PTU is preferred in the first trimester.

6. Carbimazole embryopathy is a classic exam topic.

7. Levothyroxine requirements increase during pregnancy.

8. Thyroid receptor antibodies can cross the placenta.

9. Postpartum thyroiditis often follows a biphasic pattern.

10. Total T4 is less reliable in pregnancy because TBG increases.

Practical examples / mini-cases

Mini-case

A 28-year-old woman at 10 weeks’ gestation presents with severe vomiting and weight loss. Blood tests show:

• TSH: undetectable

• Free T4: mildly elevated

She has no goitre, tremor, or eye signs.

What is the most likely diagnosis?

Answer: Gestational transient thyrotoxicosis

Explanation

Peak hCG levels occur during the first trimester and may transiently stimulate the thyroid gland. Hyperemesis gravidarum is strongly associated with this condition.

The absence of thyroid eye disease or goitre makes Graves’ disease less likely.

A practical study-tip checklist

Before the exam, ensure you can:

• Interpret thyroid function tests by trimester

• Differentiate gestational thyrotoxicosis from Graves’ disease

• Recall PTU vs carbimazole indications

• Recognise postpartum thyroiditis patterns

• Identify pregnancy complications of hypothyroidism

• Recall antibody transfer effects on the fetus

• Understand why total T4 rises in pregnancy

• Avoid overdiagnosing thyrotoxicosis in early gestation

Using timed endocrine questions from the Free MRCP MCQs and integrated revision through the MRCP lectures can help consolidate these concepts rapidly.

Common pitfalls (5 bullets)

• Treating physiological first-trimester TSH suppression as Graves’ disease

• Forgetting that hCG peaks around 10–12 weeks

• Using total T4 alone to diagnose hyperthyroidism

• Prescribing carbimazole during the first trimester without considering embryopathy

• Missing postpartum thyroiditis in a woman with mood symptoms and fatigue after delivery

FAQs

Can hCG cause hyperthyroidism in pregnancy?

Yes. High hCG levels can stimulate the TSH receptor and produce transient biochemical hyperthyroidism, particularly in the first trimester.

Why is TSH low during early pregnancy?

hCG has mild TSH-like activity. During peak hCG production, pituitary TSH secretion may become suppressed.

What is the preferred antithyroid drug in the first trimester?

Propylthiouracil (PTU) is preferred initially because carbimazole is associated with congenital malformations when used early in pregnancy.

How does pregnancy affect total T4 levels?

Oestrogen increases thyroxine-binding globulin (TBG), causing total T4 and T3 levels to rise during pregnancy.

What is the difference between Graves’ disease and gestational thyrotoxicosis?

Gestational thyrotoxicosis is transient, hCG-mediated, and lacks thyroid eye disease or thyroid antibodies. Graves’ disease is autoimmune and usually persistent.

Ready to start?

Building confidence in endocrine physiology is essential for success in MRCP Part 1. Strengthen your revision with the MRCP Part 1 overview, practise high-yield endocrine stems using the Free MRCP MCQs, and benchmark your progress with a mock test.

Sources

• MRCP(UK) examination blueprint and sample content

• National Institute for Health and Care Excellence (NICE) guidance on thyroid disease in pregnancy

• British Thyroid Association guidelines

• Williams Obstetrics

• Oxford Handbook of Clinical Medicine